Evidence map›Paper›PMID 42110626›Full record

ArticleArchives of medical science : AMS2026

lncRNA EGOT across cancers: TCGA analysis.

Tomasz Kolenda, Joanna Kozłowska-Masłoń, Kacper Guglas, Piotr Białas, Patrycja Mantaj, Paulina Poter, Anna Florczak, Anna Zapłata, Anna Malicka-Durczak, Dominika Połczyńska-Hałas and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tomasz KolendaGreater Poland Cancer Center, Research and Implementation Unit, Poznan, Poland.
Joanna Kozłowska-MasłońGreater Poland Cancer Center, Research and Implementation Unit, Poznan, Poland.
Kacper GuglasGreater Poland Cancer Center, Research and Implementation Unit, Poznan, Poland.
Piotr BiałasChair and Department of Cell Biology, Poznan University of Medical Sciences, Poznan, Poland.
Patrycja MantajRadiation Protection Department, Greater Poland Cancer Centre, Poznan, Poland.
Paulina PoterDepartment of Tumor Pathology and Prophylaxis, Greater Poland Cancer Center, Poznan, Poland.
Anna FlorczakDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland.
Anna ZapłataDepartment of Laboratory Diagnostics, Greater Poland Cancer Centre, Poznan, Poland.
Anna Malicka-DurczakDepartment of Tumor Pathology and Prophylaxis, Greater Poland Cancer Center, Poznan, Poland.
Dominika Połczyńska-HałasDepartment of Tumor Pathology and Prophylaxis, Greater Poland Cancer Center, Poznan, Poland.
Małgorzata NowakDepartment of Tumor Pathology and Prophylaxis, Greater Poland Cancer Center, Poznan, Poland.
Marlena Janiczek-PolewskaDepartment of Clinical Oncology, Greater Poland Cancer Center, Poznan, Poland.
Anna PrzybyłaDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland.
Zefiryn CybulskiGreater Poland Cancer Center, Research and Implementation Unit, Poznan, Poland.
Ewa LeporowskaDepartment of Laboratory Diagnostics, Greater Poland Cancer Centre, Poznan, Poland.
Urszula KazimierczakDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland.
Joanna KazmierskaElectroradiology Department, University of Medical Sciences, Poznan, Poland, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Long-non-coding RNAs (lncRNAs) are emerging as important regulators in the epigenetic control of cellular phenotypes. Among them, the eosinophil granule ontogeny transcript ( Material and methods: Results: We observed an association of higher Conclusions:

Indexed as

biomarkerlncRNAnon-coding RNAoncogenesuppressorTCGAviruses-depending oncogenesis

Identifiers

PMID42110626
PMCPMC13154789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.